Approval
No approved use
In September 2026, BPC-157 held no FDA approval as a medicine, for any purpose.
Claim sourceFDA briefing document
Quick card
Keep this page open while comparing an online offer.

Approval
In September 2026, BPC-157 held no FDA approval as a medicine, for any purpose.
Claim sourceFDA briefing document
Evidence
As of September 2026, no completed injury trial that compared BPC-157 with a dummy treatment had reported results.
Claim sourceClinicalTrials.gov records
Safety
The FDA said the human studies were too short and too small to establish that BPC-157 is safe.
Claim sourceFDA briefing document
Price
Because no approved BPC-157 product existed in September 2026, it had neither an official maker price nor a government price.
Claim sourceFDA briefing document
Sport
The world anti-doping list in force during 2026 named BPC-157 as prohibited both in and out of competition.
Claim sourceWorld anti-doping list
End of this page. A list of every page in this guide is just below.